Evidence map›Paper›PMID 34055654›Full record

ArticleFrontiers in oncology2021

Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report.

Tetsuya Yamamoto, Taigo Kato, Koji Hatano, Atsunari Kawashima, Takeshi Ujike, Shinichiro Fukuhara, Hiroshi Kiuchi, Ryoichi Imamura, Naokazu Ibuki, Kazuma Kiyotani and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Tetsuya YamamotoDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Taigo KatoDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Koji HatanoDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Atsunari KawashimaDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Takeshi UjikeDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Shinichiro FukuharaDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Hiroshi KiuchiDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Ryoichi ImamuraDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Naokazu IbukiDepartment of Urology, Osaka Medical College, Osaka, Japan.
Kazuma KiyotaniCancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
Masako KurashigeDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
Eichi MoriiDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
Kazutoshi FujitaDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Norio NonomuraDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Motohide UemuraDepartment of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Osaka University · JPJapanese Foundation For Cancer Research · JPOsaka Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberous sclerosis complex is a genetic disorder characterized by facial angiofibromas, intellectual disability, epilepsy, and tumor formation in multiple organs, including the kidney. Renal cell carcinoma occurs in 2%-4% of patients with tuberous sclerosis complex, often developing multiply and bilaterally. Renal cell carcinoma associated with this genetic disorder may include complex tumor heterogeneity caused by the spatially different mutational landscape. Herein, we report the case of a female patient with tuberous sclerosis complex who developed multiple renal tumors. A 44-year-old female patient with tuberous sclerosis complex developed three different histological types of tumor-angiomyolipoma, clear cell renal cell carcinoma, and papillary renal cell carcinoma-in the left kidney at first renal cell carcinoma recurrence. The papillary renal cell carcinoma was morphologically atypical, indicating that its occurrence was associated with the genetic disorder. Furthermore, whole-exome sequencing revealed distinct patterns of somatic mutation in the three tumor types, and the atypical papillary renal cell carcinoma possessed a different mutational landscape than that of typical papillary renal cell carcinomas. Our findings indicate that tumors associated with tuberous sclerosis complex may be diagnosed with careful pathological examination. Furthermore, somatic mutation profiles of these tumors revealed their unique features, providing important information for further understanding the mechanism of multiple tumor development in patients with tuberous sclerosis complex.

Indexed as

cancer genepapillary renal cell carcinomarenal cell carcinomatuberous sclerosis complexwhole-exome sequencing

Identifiers

PMID34055654
PMCPMC8149899
OpenAlexW3161765759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.